Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0AR1Y
|
||||
| Former ID |
DNC009975
|
||||
| Drug Name |
1,4-bis(malimido)xylene
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530251] | ||
| Formula |
C16H12N2O4
|
||||
| Canonical SMILES |
C1=CC(=CC=C1CN2C(=O)C=CC2=O)CN3C(=O)C=CC3=O
|
||||
| InChI |
1S/C16H12N2O4/c19-13-5-6-14(20)17(13)9-11-1-2-12(4-3-11)10-18-15(21)7-8-16(18)22/h1-8H,9-10H2
|
||||
| InChIKey |
XFRPTDABLAIJMY-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530251] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.